Generating dopamine via cell therapy for Parkinson’s disease

Public release date: 2-Jul-2012 [ | E-mail | Share ]

Contact: Sarah Jackson press_releases@the-jci.org Journal of Clinical Investigation

In Parkinson's disease, the loss of dopamine-producing cells in the midbrain causes well-characterized motor symptoms. Though embryonic stem cells could potentially be used to replace dopaminergic (DA) neurons in Parkinson's disease patients, such cell therapy options must still overcome technical obstacles before the approach is ready for the clinic. Embryonic stem cell-based transplantation regimens carry a risk of introducing inappropriate cells or even cancer-prone cells. To develop cell purification strategies to minimize these risks, Dr. Lorenza Studer and colleagues at Memorial Sloan Kettering Cancer Center in New York developed three different mouse lines to fluorescently label dopaminergic neurons at early, mid, and late stages of differentiation. Their data suggest that mouse embryonic stem cells induced to the mid stage of neuronal differentiation are best suited for transplantation to replace dopaminergic neurons. Further, their work identified new genes associated with each stage of neuronal differentiation. Their results in the mouse model system help define the differentiation stage and specific attributes of embryonic stem cell-derived, dopamine-generating cells that hold promise for cell therapy applications.

###

TITLE:

Identification of embryonic stem cellderived midbrain dopaminergic neurons for engraftment

AUTHOR CONTACT:

Lorenz Studer

Memorial Sloan Kettering Cancer Center, New York, NY, USA

Phone: 212.639.6126; E-mail: studerl@mskcc.org

Read more here:
Generating dopamine via cell therapy for Parkinson's disease

Amicus Therapeutics Announces Publication of BLISS Quantitative Histology Method in Archives of Pathology & Laboratory …

CRANBURY, N.J., July 2, 2012 (GLOBE NEWSWIRE) -- Amicus Therapeutics, Inc. (FOLD), a biopharmaceutical company at the forefront of therapies for rare and orphan diseases, today announced that a manuscript describing the Barisoni Lipid Inclusion Scoring System (BLISS) has been published in the July 2012 issue of Archives of Pathology & Laboratory Medicine. The manuscript titled, "A Novel, Quantitative Method to Evaluate GL-3 Inclusions in Renal Peritubular Capillaries by Virtual Microscopy in Patients with Fabry Disease,"1 is currently available online.

BLISS improves the ability to detect and quantify changes in globotriaosylceramide (GL-3) peritubular capillary (PTC) inclusions - also referred to as interstitial capillaries - in females and males with Fabry disease. GL-3 is the lipid substrate that accumulates in tissues affected by Fabry disease, including the kidney. BLISS was developed by Dr. Laura Barisoni while she was an Associate Professor in Pathology and Medicine at the New York University School of Medicine, in collaboration with Amicus. Dr. Barisoni is currently a Voluntary Associate Professor in Pathology at the University of Miami.

In a Phase 3 study (Study 011) intended for U.S. registration of migalastat HCl monotherapy for Fabry disease, BLISS with virtual microscopy will be utilized for the histological evaluation of interstitial capillary GL-3 in kidney biopsies, the primary endpoint. Migalastat HCl is an oral investigational pharmacological chaperone for Fabry disease being developed by Amicus in collaboration with GlaxoSmithKline (GSK).

Previous pivotal studies of enzyme replacement therapy (ERT) for Fabry disease used a semi-quantitative approach with conventional light microscopy. Pathologist readers manually searched for and categorically scored PTC GL-3 (0, 1, 2, or 3) within the same histological sections, but not necessarily in the same PTCs. A more sensitive methodology was needed to more accurately and reliably quantify GL-3 inclusions, and to assess response to treatment, particularly in patients who have lower amounts of GL-3.

Published Results

The study published by Dr. Barisoni and colleagues compared BLISS to the previously reported semi-quantitative scoring method. Intra- and inter-reader variability was also assessed using BLISS in combination with virtual microscopy (BLISS-VM) versus conventional light microscopy (BLISS-LM). The novel BLISS-VM protocol was created by the pathology team composed of Dr. Barisoni; Dr. Charles Jennette, Professor and Chair at the University of North Carolina-Chapel Hill; and Dr. Robert Colvin, Professor in Pathology at the Massachusetts General Hospital.

Pre-treatment kidney biopsies were scored from 17 patients (eight males and nine females) enrolled in three Phase 2 studies of migalastat HCl. Results demonstrated that BLISS is a more sensitive scoring system to measure GL-3 inclusions in PTCs compared to the semi-quantitative methodology. The addition of virtual microscopy further improved accuracy and reproducibility of BLISS, reducing intra- and inter-reader variability. BLISS-VM used one pathologist annotator to identify PTCs on a scanned digital slide image, and different pathologist readers to score the total number of GL-3 inclusions in each PTC identified by the annotator. The annotation step ensures that both readers are scoring the same PTCs. Results are digitally recorded as each PTC is scored to prevent double counting. The scored digital images also provide a permanent and retrievable record for clinical studies and submission to regulatory authorities.

Dr. Barisoni stated, "We developed BLISS as a novel quantitative methodology to detect GL-3 in both male and female Fabry patients. Our study showed that BLISS was able to detect GL-3 inclusions that were missed by the semi-quantitative scoring method. While the traditional semi-quantitative methodology can measure GL-3 inclusions in patients with a high level of GL-3 storage, a large percentage of Fabry patients have some residual enzyme activity and fewer GL-3 inclusions. In addition, innovations in digital imaging have made it possible to incorporate virtual microscopy to address several limitations of conventional light-based microscopy."

Drs. Barisoni, Jennette, and Colvin will utilize BLISS-VM to score the kidney biopsies of Fabry patients in Study 011. Amicus and GlaxoSmithKline (GSK) are on track to report results from this study in the third quarter of 2012.

1. Barisoni L.1, Jennette J.C.2, Colvin R.3, Sitaraman S.4, Bragat A.4, Castelli J.4, Boudes P.4, Archives of Pathology & Laboratory Medicine: July 2012, Vol. 136, No. 7, pp. 816-824.

More here:
Amicus Therapeutics Announces Publication of BLISS Quantitative Histology Method in Archives of Pathology & Laboratory ...

Nationwide Planting of Vegetables in Schools Kicks-Off Nutrition Month Celebration

July 2 marks the official start of this years Nutrition Month celebration guided by the theme Pagkain ng gulay ugaliin, araw-araw itong ihain!. The National Nutrition Council of the Department of Health kicks-off the nationwide celebration with the planting of vegetables by school children of the ConcepcionElementary Schoolin Marikina City.

The children will be joined by Health Secretary and NNC Chair Enrique Ona, Agriculture Secretary Proceso Alcala, Social Welfare Secretary Dinky Soliman and Education Secretary Armin Luistro together with NNC Executive Director and concurrent Assistant Secretary of Health Maria-Bernardita Flores.

Thousands of school children are expected to plant vegetables in public elementary schools. The Department of Education issued a memorandum encouraging all schools to celebrate Nutrition Month with the simultaneous planting of vegetables as part of its share to promote consumption of vegetables among children as part of a healthy diet.

This years Nutrition Month celebration aims to encourage every Filipino to eat more vegetables, i.e. 3 servings or more per day, to add more vitamins and minerals in the diet as well as prevent non-communicable diseases such as various forms of cancer, cardiovascular disease and diabetes. As vegetables have less calories, adding them to the diet can help people to reduce weight or maintain normal body weight. A serving of vegetable is equal to a cup of raw leafy vegetables or cup of raw or cooked non-leafy vegetables.

The campaign is in response to the finding that the average Filipino eats less and less vegetables per day in the past 30 years. Based on the food consumption surveys of the Food and Nutrition Research Institute, Filipinos eat only about 2 servings of vegetables on average or about 110 grams. The vegetable consumption has been declining since 1978 when Filipinos still ate 145 grams per day. The data is alarming considering that low fruit and vegetable intake is among the top 10 selected risk factors for global mortality based on a World Health Organization Report. The report also showed that 1.7 million deaths are due to low intake of fruits and vegetables.

The Nutrition Month campaign also aims to encourage families, schools and communities to put up vegetable gardens to ensure supply of fresh and nutritious vegetables. The FNRI also reported that only 67.7% of Filipino households have vegetable gardens or fruit trees. Having vegetable gardens can help in reducing malnutrition and hunger especially among poor families.

According to A/Sec. Flores, The NNC encourages everyone to consume three or more servings of vegetables each day. Lets also eat our indigenous vegetables such as malunggay, saluyot, kangkong, kamote tops and ampalaya. Let us also plant vegetables in all possible places. Even if there is no available space in many urban communities, , there are many urban gardening technologies such as container gardening and the use of hydroponics or soil-less gardening that can be used.

A/Sec Flores also added that Young infants starting at 6 months, should be given pureed, mashed and finely cut green leafy and yellow vegetables. This can be added to thick lugaw to make for a nutritious complementary food in addition to breastmilk. The NNC is very concerned that infants 6-11 months old had an intake of only 2 grams of vegetables while 1 year old children had an intake of 8 grams per day on average. For young children, vegetables are important sources of vitamin A and iron which are important nutrients that improve childrens immune system, growth and development.

Other government agencies, non-government organizations, local government units, private sector and civil society are expected to also conduct various activities to help in promoting vegetables consumption.

See the original post here:
Nationwide Planting of Vegetables in Schools Kicks-Off Nutrition Month Celebration

Schiff Nutrition Appoints Richard F. Baruch Jr. Senior Vice President – Chief Commercial Officer

SALT LAKE CITY--(BUSINESS WIRE)--

Schiff Nutrition International, Inc. (SHF) appointed, effective today, Richard F. Baruch Jr., 44, to the new position of Senior Vice President Chief Commercial Officer.

Rich brings an extensive background in sales, marketing and general management, and we welcome him to the team, stated Tarang Amin, president and chief executive officer of Schiff Nutrition. With over 20 years of experience expanding brands and delivering results at leading companies such as Coca-Cola, Clorox, and Procter & Gamble, we believe Rich will help broaden our commercial opportunities.

Baruch stated: I am excited to join Schiff and I believe my skill set complements Schiffs strong leadership team. Together, we can drive further growth, particularly in our efforts to expand the channel and geographic footprint of the company.

Baruch most recently served as Vice President Category Advisory Services at Coca-Cola where he led an initiative to build a new organization and bring a new set of capabilities to Coca-Colas North American business. Prior to that, Baruch was President and Chief Operating Officer of CotnWash, Inc. where he led the national launch of Dropps laundry detergent and grew overall top-line revenue by over 300% over two years. Previously, Baruch spent fourteen years at The Clorox Company in a number of leadership roles, with the most recent being Vice President and General Manager of the Home Care business. He began his career at Procter & Gamble in various sales management roles. Baruch holds a bachelors degree from the University of Pennsylvania.

About Schiff Nutrition

Schiff Nutrition International, Inc. is a leading nutritional supplement company offering vitamins, nutritional supplements and nutrition bars in the United States and abroad. Schiffs portfolio of well-known brands includes Move Free, MegaRed, Airborne, Tiger's Milk, Sustenex, Digestive Advantage and Schiff Vitamins. Focused on quality for 75 years, Schiffs headquarters and award-winning manufacturing and distribution facility are based in Salt Lake City, Utah. To learn more about Schiff, please visit the web site http://www.schiffnutrition.com.

See the article here:
Schiff Nutrition Appoints Richard F. Baruch Jr. Senior Vice President - Chief Commercial Officer

What Diving Seabirds Can Tell Us About Our Own Longevity

July 2, 2012

[ Watch the Video ]

redOrbit Staff & Wire Reports Your Universe Online

Diving seabirds reach their 30s and then die swiftly and unexpectedly, showing little signs of aging prior to their death. Studying these birds could help us understand the aging process and provide critical insights for our aging citizens.

Researchers studied Guillemots which look similar to penguins but can fly over four summers. During this time, they periodically tracked Brnnichs guillemots fitness, recording depth and for how long they would dive for prey, how far and fast they would fly, and how much energy they used on these activities. They also looked for changes in the birds behavior and metabolism.

Guillemots have the highest flight outlay of any bird and use large amounts of energy for diving. Their high metabolisms and frequent dives should produce oxidative stress, causing the birds to weaken as they age. However, the researchers discovered that the birds stay fit and active as they grow older, maintaining their flying, diving, and foraging abilities.

Kyle Elliott, a PhD student at the University of Manitoba and the studys lead author, said, Most of what we know about aging is from studies of short-lived round worms, fruit flies, mice, and chickens, but long-lived animals age differently. We need data from long-lived animals, and one good example is long-lived seabirds.

Elliott also said, Not only do these birds live very long, but they maintain their energetic lifestyle in a very extreme environment into old age.

One bird, nicknamed Wayne Gretzky by the researchers (after the Canadian hockey great who played 20 seasons and because the birds band of colors matched Gretzkys team colors), raised young for 18 uninterrupted years.

The findings will be presented today at the Society for Experimental Biology meeting in Salzburg.

See the original post here:
What Diving Seabirds Can Tell Us About Our Own Longevity

DNA Results Negative For Angeline Quinto, Purported Mother

The key to Angelines true identity remains elusive (File Photo)

MANILA, Philippines It seems singer Angeline Quintos quest to find her biological mother has not yet come to an end.

Although frustrated and emotional after the recent DNA test she underwent together with Veronica Tolentino, the woman claiming to be her biological mom, came back negative, Quinto vowed to continue searching for her real mother.

Sabi ko nga po sa tatay ko, tulungan niyo rin naman po ako na sana may magawa rin siya para makita namin ang totoo kong nanay, Quinto shared in a taped interview with The Buzz aired on July 1.

Aside from Tolentino, Quintos father Pop Quiros, also subjected himself to a DNA testing. Unlike Tolentino, the test yielded a positive result for Quiros, which means that shes Quintos biological father.

Natutuwa po ako na si Papa ko talagang tatay ko po at siyempre 'yung mga nakilala ko po na mga kapamilya ko simula noong bata ako, talagang kapamilya ko po, she said.

However, Quinto, for her part, felt sorry that she got a negative result when her DNA was cross-examined with Tolentinos.

Nakita niyo naman po kung ano ang reaction ni Aling Veronica, talagang umiyak siya noong niyakap niya ako. Sabi ko nga po, Pasensya na po kayo, siguro po ganoon talaga, the singer recalled.

Feeling for Tolentino, Quinto related that shes praying for her to eventually find her own biological daughter whom shes been searching for, for so long.

As for her own search, Quinto vowed that this is not the end; just the beginning of yet another chapter.

Originally posted here:
DNA Results Negative For Angeline Quinto, Purported Mother

Posted in DNA

Humble DNA could help decipher dark matter

A few strands of DNA could help solve the mystery of dark matter. A newly proposed detector aims to use DNA to resolve the conflicting claims from current dark matter detectors.

Dark matter is thought to make up about 85 per cent of the matter in the universe. The prime suspects are so-called weakly interacting massive particles, which are immune to the electromagnetic and strong nuclear forces. In theory, WIMPs interact with normal matter only via gravity and the weak nuclear force.

Attempts to detect WIMPs on Earth have provided conflicting results. On the positive front, two experiments CoGeNT in Soudan, Minnesota, and DAMA/LIBRA at Gran Sasso, Italy have seen more putative dark matter particles hitting their detectors in June than in December. All else being equal, the excess is attributed to Earth's relative velocity through the sea of dark matter that fills our galaxy. In June, Earth is moving in the same direction as the sun and so encounters a "headwind" of dark matter, the theory goes. In December, Earth, in its orbit around the sun, is moving in the opposite direction.

But, crucially, other bigger and more sensitive experiments, such as CDMS-II and XENON1O0, have seen no such particles. One way to resolve the conflict would be to detect the directionality of dark matter particles, to see if they are indeed aligned with the direction of the sun's motion through the galaxy, as required by DAMA/LIBRA and CoGeNT.

Now Andrzej Drukier of Biotraces a biotech firm based in Herndon, Virginia and a group of cosmologists and biochemists are suggesting that DNA could help break the impasse.

Their proposed detector consists of a 1-metre-square sheet of gold foil and a "forest" of single-strand DNA molecules suspended beneath in an ordered array, like the bristles on a toothbrush. When a WIMP strikes a gold atom in the foil, it would dislodge a gold nucleus and send it careening through the array, severing the DNA strands along its path. Energetic particles like cosmic rays have been shown to collide with and break strands of DNA, though WIMPs would have much lower energy.

The broken DNA strands would be gathered, amplified and analysed to determine exactly where each strand was severed. Given that the sequence of bases that make up each DNA strand is well known, the location of the cut on each strand and hence the path of the gold nucleus could be tracked to within a nanometre in three dimensions, around 1000 times better resolution than current detectors.

"The higher resolution means that we would get more data per WIMP event," says team member George Church of Harvard University.

Such 3D resolution would allow cosmologists to infer the both the energy and the direction of a WIMP, which could in turn confirm the existence of the predicted "WIMP wind" created by the solar system's motion through the galaxy.

A DNA-based detector has other advantages too, the team claims. It can operate at room temperature, as opposed to near absolute zero for current detectors. And by changing the material of the foil, it can be tuned to look for particles of different energies, including the WIMPs apparently detected by CoGeNT and DAMA/LIBRA. The team is now testing the feasibility of the design.

Read more from the original source:
Humble DNA could help decipher dark matter

Posted in DNA

How A 'DNA Tracking Chamber' Could Detect Dark Matter

Perhaps the greatest and most fiercely contested race in modern science is the search for dark matter.

Physicists cannot see this stuff, hence the name. However, they infer its existence because they can see its gravitational influence on the structure of galaxies and clusters of galaxies. It implies that the universe is filled with dark matter, much more of it than the visible matter we can see

If they're right, dark matter must fill our galaxy and our Solar System. At this very instant, we ought to be ploughing our way through a dense sea of dark matter as the Sun moves towards the constellation of Cygnus as it orbits the galactic centre.

That's why various groups are racing to detect this stuff using expensive detectors in deep underground caverns, which shield them from radiation that would otherwise swamp the signal.

These experiments are looking for the unique signature that dark matter is thought to produce as a result of the Earth's passage around the Sun. During one half of the year, the dark matter forms headwind as the Earth ploughs into it; for the other half of the year, it forms a tailwind.

Indeed, a couple of groups claim to have found exactly this diurnal signature, although the results are highly controversial and seem to be in direct conflict with other groups who say they have not seen it.

There's a a straightforward way to make better observations that should solve this conundrum. The dark matter signal should vary, not just over the course of a year, but throughout the day as the Earth rotates.

The dark matter headwind should be coming from the direction of Cygnus, so a suitable detector should see the direction change as the Earth rotates each day.

There's a problem, however: nobody has built a directional dark matter detector.

That's why a revolutionary new idea from an unlikely collaboration of physicists and biologists looks rather exciting. The group brings together diverse people, such as Katherine Freese at the University of Michigan in Ann Arbor, an astrophysicist and one of the leading thinkers in the area of dark matter, and George Church at Harvard University in Cambridge, a geneticist and a pioneer in the area of genome sequencing.

Link:
How A 'DNA Tracking Chamber' Could Detect Dark Matter

Posted in DNA

Revolutionary 'DNA Tracking Chamber' Could Detect Dark Matter

Perhaps the greatest and most fiercely contested race in modern science is the search for dark matter.

Physicists cannot see this stuff, hence the name. However, they infer its existence because they can see its gravitational influence on the structure of galaxies and clusters of galaxies. It implies that the universe is filled with dark matter, much more of it than the visible matter we can see

If they're right, dark matter must fill our galaxy and our Solar System. At this very instant, we ought to be ploughing our way through a dense sea of dark matter as the Sun moves towards the constellation of Cygnus as it orbits the galactic centre.

That's why various groups are racing to detect this stuff using expensive detectors in deep underground caverns, which shield them from radiation that would otherwise swamp the signal.

These experiments are looking for the unique signature that dark matter is thought to produce as a result of the Earth's passage around the Sun. During one half of the year, the dark matter forms headwind as the Earth ploughs into it; for the other half of the year, it forms a tailwind.

Indeed, a couple of groups claim to have found exactly this diurnal signature, although the results are highly controversial and seem to be in direct conflict with other groups who say they have not seen it.

There's a a straightforward way to make better observations that should solve this conundrum. The dark matter signal should vary, not just over the course of a year, but throughout the day as the Earth rotates.

The dark matter headwind should be coming from the direction of Cygnus, so a suitable detector should see the direction change as the Earth rotates each day.

There's a problem, however: nobody has built a directional dark matter detector.

That's why a revolutionary new idea from an unlikely collaboration of physicists and biologists looks rather exciting. The group brings together diverse people, such as Katherine Freese at the University of Michigan in Ann Arbor, an astrophysicist and one of the leading thinkers in the area of dark matter, and George Church at Harvard University in Cambridge, a geneticist and a pioneer in the area of genome sequencing.

Visit link:
Revolutionary 'DNA Tracking Chamber' Could Detect Dark Matter

Posted in DNA

DNA Methylation Linked to Memory Loss

Scientists find that declining DNA methylation in mouse neurons may cause age-related memory deficits.

Researchis increasingly connecting changes in epigenetic regulation of gene expression to the aging process. Many studies demonstrate that DNA methylation declines with age. Now, new research published yesterday (July 1) in Nature Neuroscience links DNA methylation with brain aging. Researchers show that levels of an enzyme that attaches methyl groups to cytosine nucleotides throughout the genome is linked to cognitive decline, and that its overexpression can restore performance of aging mice on memory-related tasks.

We already know normal aging is associated with cognitive decline, but this paper links that with expression a specific DNA methyltransferase, said Yuan Gao, an epigeneticist at the Lieber Institute for Brain Development in Maryland, who did not participate in the study. The current work also builds on other studies demonstrating that proper regulation of methylation in brain cells is critical to memory formation. Previous studies have suggested a connection between loss of DNA methylation and Alzheimers disease, said Gao, suggesting that if researchers could restore [methyltransferase] activity and cure or delay dementia, it would make a nice model for developing drugs to tackle age-related cognitive diseases.

DNA methylation, wherein a methyl group is attached to a cytosine next to a guanosine, is one form of epigenetic regulation that can modulate how available genes are to the cells transcription machinery, and thus how highly expressed they are. Scientists already appreciate how differences in epigenetic regulation can affect development of diseases like cancer, without need for gene mutations. Studies are also accumulating that correlate declining methylation with aging, although the mechanism remains unclear.

Classically, DNA methylation is considered a repressive modification, but that view is beginning to change, suggesting a more nuanced role for methylation in gene regulation, explained senior author Hilmar Bading of the University of Heidelberg. The twist in Badings current research is that the methyltransferase his group focuses on, Dnmt3a2, may be working to enable gene transcription, rather than repress it.

This gene-activating role may stem from methylation that blocks repressors, rather than activators, explained Trygve Tollesfbol, who investigates the role of epigenetics in cancer and aging at the University of Alabama, who did not participate in the research. Whether methylation is located in the promoter or body of the gene can also determine whether it inhibits or enhances transcription, explained Guoping Fan, who studies epigenetic regulation of neuron development at the University of California, Los Angeles.

Badings group identified Dnmt3a2 when looking for genes that are upregulated by neuronal activity. Knowing that DNA methylation decreases with age, first author Ana Oliviera compared Dnmt3a2 expression in 3-month-old and 18-month-old mice, and found lower levels of Dnmt3a2 in the older mice. Furthermore, learning tasks designed to stimulate hippocampus neurons failed to upregulate Dnmt3a2 expression in old mice as robustly as in young mice.

Theorizing that reduced Dnmt3a2-dependent DNA methylation contributed to older mices poorer performance on learning and memory tasks, the scientists used an adeno-associated virus to supplement Dnmt3a2 expression in their hippocampal neurons. Boosting its expression enhanced both brain methylation in the older mice, and their ability to learn. Conversely, when the researchers used short hairpin RNA to knockdown Dnmt3a2 expression in young mice, their performance on learning and memory tests worsened.

I think Dnmt3a2 has a basic gating function, said Bading. Neurons need to turn genes on and off quickly in response to changing stimulation. Bading hypothesizes that Dnmt3a2-dependent methylation helps keep geneslike brain-derived neurotrophic factor (BDNF) and Arc, both regulated by Dnmt3a2 and both involved in responses to signaling changesreceptive to changing stimulation, putting the genome in the right state for being inducible, Bading said. Genes like BDNF shouldnt be transcribed all the time, but it may be that without Dnmt3a2-dependent methylation, the door is closed neurons cant express them when they need to.

This could set up a vicious cycle, Bading explained, because Dnmt3a2 is also induced by neuronal activity. Less Dnmt3a2 would result in less expression of methylation-dependent genes, possibly including Dnmt3a2 itself, and the effect would worsen over time. It would take many years to add up, but aging takes years, Bading noted.

Go here to read the rest:
DNA Methylation Linked to Memory Loss

Posted in DNA

Cell biology — new insights into the life of microtubules

Public release date: 2-Jul-2012 [ | E-mail | Share ]

Contact: Dr. Kathrin Bilgeri kathrin.bilgeri@lmu.de 49-892-180-6938 Ludwig-Maximilians-Universitt Mnchen

Every second, around 25 million cell divisions take place in our bodies. This process is driven by microtubule filaments which continually grow and shrink. A new study shows how so-called motor proteins in the cytosol can control their dynamics.

The cytoskeleton plays a central role in the process of cell division. It is composed in large part of protein filaments known as microtubules, which also help determine the size, shape and mobility of a cell. In a new study, LMU biophysicist Erwin Frey and his colleagues Anna Melbinger and Louis Reese have used a theoretical model to show how cells control the construction and breakdown of microtubules. The dy-namics of this process affect how cells divide, and how they maintain the cytoskeleton. In particular, it is responsible for regulating the size and shape of the mitotic spindle.

Easy come, easy go

Theoretical modeling has now revealed that the regulation of microtubule length relies on the length of the filament itself: The longer the filament the more motor proteins can attach to it. These all move towards the 'plus end' of the microtubule and tend to pile up as they do so. Upon arrival at the plus-end they shorten the filament. In parallel, new microtubule building blocks bind to precisely the same 'plus end' through spontaneous polymerization from the surrounding cytosol, and the filament grows.

It has now been demonstrated that such interplay between growth and length-dependent shrinkage indeed results in the maintenance of a precisely regulated microtubule length. This kind of length regulation might be essential for many intracellular tasks which depend on microtubules of a certain length. (Physical Review Letters, 22. June 2012)

###

This work was supported by the Cluster of Excellence "Nanosystems Initiative Munich" (NIM) and SFB 863 (Forces in Biomolecular Systems)

Publication: Microtubule Length Regulation by Molecular Motors Anna Melbinger, Louis Reese, and Erwin Frey Phys. Rev. Lett. 108, 258104 (2012). Published online June 22, 2012

Read the original:
Cell biology -- new insights into the life of microtubules

FMRI Brain Scanner Reads Thoughts Letter By Letter

Featured Article Academic Journal Main Category: MRI / PET / Ultrasound Also Included In: Neurology / Neuroscience;Medical Devices / Diagnostics;Biology / Biochemistry Article Date: 02 Jul 2012 - 3:00 PDT

Current ratings for: FMRI Brain Scanner Reads Thoughts Letter By Letter

5 (1 votes)

4.5 (2 votes)

Bettina Sorger of Maastricht University in The Netherlands and colleagues report their work in the 28 June online issue of Current Biology.

Human communication depends on being able to move and use a multiplicity of muscles, such as in forming sounds and words and making gestures and facial expressions. To do this the neuromuscular system must be healthy and undamaged. But severely motor-disabled patients, such as those with locked-in syndrome, who are fully conscious and aware, can't have a back-and-forth conversation because their neuromuscular system is not intact.

The challenge to scientists trying to find ways to enable such patients to communicate is to tap into those parts of the brain that are performing the mental tasks of communication but are denied the means with which to express them physically, using the motor system or voluntary muscles.

fMRI tracks brain activity by measuring changes in blood flow (hemodynamics) and oxygen in the brain. When a brain area is more active it uses more oxygen, and to meet this increase in demand, the blood flow to the area increases. Thus using fMRI, researchers can produce activation maps that show which parts of the brain are involved in particular brain processes.

Neuroscientists like Adrian Owen and his team have already used fMRI to assess consciousness in people thought to be in an unconscious vegetative state and thus incapable of thought, and enabled them to respond yes or no to questions.

This latest study by Sorger and colleagues takes that work a stage further, as Sorger explained to the press:

Read more from the original source:
FMRI Brain Scanner Reads Thoughts Letter By Letter

12 new medical residents are selected as region tries to address physician shortage

SANTA ROSA The Family Medicine Residency Program at Sutter Medical Center of Santa Rosa announced its incoming class of 2015, selecting 12 medical school graduates out of 618 applicants about half of the nations 1,200 plus applicants in family medicine.

The three-year program, one of 450 family medicine training programs in the United States, is affiliated with the UCSF School of Medicine and has trained hundreds of family physicians since its inception in 1938.

And its become an increasingly vital asset to the regions health care landscape, as the county, the state and much of the nation confronts a persistent and emerging shortage of primary care physicians.

The county faces a shortage of up to 200 physicians over the next 10 years, according to a study commissioned by the Sonoma County Department of Health Services and the Sonoma County Medical Association. The study said the county has some 350 primary care physicians, which is better than the ideal range of 60 to 80 doctors per 100,000 residents. Still, an estimated 22 percent of the countys primary care physicians expected to retire and another percent 6 to 8 percent planning on leaving the area.

In addition the shortage, the nature of primary care has changed dramatically, with more and more physicians joining larger, more coordinated systems versus running a private practice.

Health care is changing in this country and the old models of family medicine, where a physician sits in the office and waits for patients to come to them, are out-dated. In our recruiting, we have positioned ourselves as one of the innovators in the world of family medicine education, said Jeff Haney, residency program director.

Copyright 19882012 North Bay Business Journal View the policy for linking to website content.

Topics: Kaiser Permanente, physician residency, physicians groups, Santa Rosa Community Health Centers, Santa Rosa Family Medicine Residency, Sonoma County, Sutter Medical Center of Santa Rosa | Categories: Employment, Health Care and Senior Living, Industry News, North Bay News, People, Position, Sonoma Report, Spotlights and Profiles, Top News Stories

See more here:
12 new medical residents are selected as region tries to address physician shortage

What It Means to Be a ‘Disadvantaged’ M.D. Applicant

Med school applicants from rural areas are among those who can claim disadvantaged status.

Many premedical students have encountered some form of hardship. So when medical school applicants see the category "Disadvantaged status" on the American Medical College Application Service (AMCAS), they may wonder what a disadvantaged status really means.

Officially, AMCAS states that applicants determine whether to designate themselves as disadvantaged. Each medical school has its own policies on how it handles applicants who self-declare the disadvantaged status, or whether it treats those applications differently. AMCAS also provides certain categories for guidance in determining status:

Underserved: If you grew up in an underserved or rural area up until the age of 18, AMCAS states that you can identify yourself as a disadvantaged applicant. When you generate your AMCAS application, you can mark your county of residence as rural (R), medically underserved (U), or both.

[Learn what to consider when applying to med school with a low GPA.]

Immediate family: If you have a situation involving your immediate family that affected your educational opportunities or social circumstances, you can self-designate as disadvantaged.

State and federal assistance programs: If your family received state and federal assistance because of socioeconomic other circumstances, it would be considered appropriate to self-designate as disadvantaged by AMCAS.

If you think there are other circumstances that have contributed to your disadvantaged statues that are not listed on the AMCAS page, don't feel constrained by the above. In addition to requesting family financial data, AMCAS provides the opportunity for a 1,325 character statement explaining why you feel you should be considered a disadvantaged applicant.

In June 2009, the Association of American Medical Colleges (AAMC) published a compendium of examples of disadvantaged applicant statements, as well as other data that characterized admissions statistics of that group.

[See why minorities still don't feel completely comfortable in medicine.]

Go here to see the original:
What It Means to Be a ‘Disadvantaged’ M.D. Applicant

Auxogyn Presents New Data Showing the Ability of Eeva(TM) to Non-Invasively Predict Embryo Advancement With Increased …

MENLO PARK, CA--(Marketwire -07/02/12)- Auxogyn, Inc., a company focused on revolutionizing the field of reproductive health, today presented data showing the ability of its flagship product, the Early Embryo Viability Assessment (Eeva) Test, to predict embryo advancement with a new level of accuracy. The Eeva Test uses intelligent computer vision software to measure key parameters from video images and predicts with high accuracy at the cleavage stage which embryos will likely grow to the blastocyst stage. These clinical data were presented today at the European Society of Human Reproduction and Embryology (ESHRE) Annual Meeting in Istanbul, Turkey.

In a prospective multi-center cohort study of 160 patients and close to 1,800 embryos, the Eeva Test was able to predict blastocyst formation at the cleavage stage with 85 percent specificity, reducing the false positive rate from 43 percent to 15 percent compared with traditional morphology selection. Eeva also demonstrated the ability to track and analyze cell division timings with greater than 90 percent accuracy. Additionally, Eeva was able to increase the consistency of embryo assessment across embryologists.

"Remarkably, we found that Eeva may in fact improve embryo selection for cleavage-stage transfer," said David Adamson, M.D., adjunct clinical professor at Stanford University, associate clinical professor at UCSF, director of Fertility Physicians of Northern California and principal investigator of the Eeva study. "Eeva provided early insights that we expect will prove to be valuable for cycle consultation and planning of future treatment with our patients. The ability to predict with an increased degree of accuracy appears to be outstanding and will change the way we care for our IVF patients."

"We are delighted that these study results both confirm the groundbreaking discovery published by Stanford University in Nature Biotechnology and demonstrate the clinical value that Eeva provides to reproductive specialists and their patients," said Lissa Goldenstein, president and chief executive officer of Auxogyn. "These data, which we included in both our CE and FDA regulatory filings, represent significant progress in our commitment to the rigorous study and validation of our technology, which we believe is essential in the IVF field."

"Given our progress to date, we expect to receive CE clearance for Eeva in the EU imminently," added Ms. Goldenstein. "We are also on track to submit our 510(k) filing to the FDA this month."

About IVFInfertility affects one of every six couples, but little or no new scientific and clinical breakthroughs in reproductive health have occurred in decades. The demand for assisted reproduction tools and procedures is growing by approximately 10 percent per year due to higher infertility rates caused by an increasing maternal age as more women are starting families later in life. The demand is growing despite the fact that, in the U.S., the cost per cycle is between $13,000 and $15,000, and only one-third of cycles result in a live birth. This necessitates the transfer of multiple embryos and/or conducting multiple cycles, leading to greater physical, emotional, practical and financial costs, before determining if pregnancy can be achieved.

About the Eeva TestAuxogyn's non-invasive, Early Embryo Viability Assessment (Eeva) Test is designed to improve IVF outcomes by providing clinicians and patients with objective information that will enable them to more confidently select embryo(s) for transfer. Eeva's proprietary software automatically analyzes embryo development against scientifically and clinically validated cell-division parameters. With Eeva's quantitative data for each embryo's potential development, IVF clinics may be able to optimize the treatment path for their patients undergoing IVF procedures. Eeva is limited by United States law to investigational use and is under clinical investigation in the European Union.

About AuxogynAuxogyn is revolutionizing the field of reproductive medicine by translating scientific discoveries in early embryo development into clinical tools. The Company's flagship product, the Eeva Test, delivers consistent, objective and quantitative information regarding embryo viability that reproductive endocrinologists and infertility patients can use to make important treatment decisions. Auxogyn is privately held and funded by Kleiner Perkins Caufield & Byers, Merck Serono Ventures, SR One and TPG Biotech. For more information regarding Auxogyn please visit http://www.auxogyn.com.

See the original post:
Auxogyn Presents New Data Showing the Ability of Eeva(TM) to Non-Invasively Predict Embryo Advancement With Increased ...

World's number of IVF and ICSI babies has now reached a calculated total of 5 million

ScienceDaily (July 2, 2012) The number of babies born as a result of assisted reproduction technologies (ART) has reached an estimated total of 5 million since the world's first, Louise Brown, was born in July 1978. The figures were presented at the 28th annual meeting of ESHRE (European Society of Human Reproduction and Embryology), which began 1st July, in Istanbul, Turkey.

The calculation was made for a presentation at the congress from ICMART (International Committee for Monitoring Assisted Reproductive Technologies) and was based on the number of IVF and ICSI treatment cycles recorded worldwide up to 2008 with estimations added for the following three years. The cumulative total of births was put at 4.6 million last year, and this year has now reached an approximate total of 5 million.

Commenting on this remarkable milestone, Dr David Adamson, from Fertility Physicians of Northern California, USA, and Chairman of ICMART, said: "It means that this technology has been highly successful in treating infertile patients. Millions of families with children have been created, thereby reducing the burden of infertility.

"The technology has improved greatly over the years to increase pregnancy rates. The babies are as healthy as those from other infertile patients who conceive spontaneously. The technology is available globally in many different cultures. The major barriers to access are economic, and societal in some situations. With these accomplishments as a technology, and with recognition of Professor Robert Edwards as a Nobel Laureate, IVF is firmly established now in the mainstream of medicine."

Other ICMART data indicate that around 1.5 million ART cycles are now performed globally each year, producing around 350,000 babies. This number continues to rise. The two most active countries of the world are the USA and Japan, but the most active region by far is Europe.

The picture in Europe

The latest European data to be presented at the ESHRE congress are for 2009, and show that demand for treatment -- as expressed in treatment cycles performed in European countries -- continues to grow, from 532,260 in 2008 to 537,287 in 2009.

The average availability of ART in Europe is close to 1000 cycles/million inhabitants, but this figure varies greatly between countries and is largely dependent on local state funding policies. Availability in Europe is greater than in the USA but less than in Australia.

Dr Anna Pia Ferraretti, chairman of ESHRE's IVF Monitoring Consortium, said that the global need for ART is estimated to be at least 1500 cycles/million population per year, a figure only seen in Denmark (2726 cycles/million), Belgium (2562 cycles), Czech Republic (1851 cycles), Slovenia (1840 cycles), Sweden (1800 cycles), Finland (1701 cycles) and Norway (1780 cycles). Countries with much lower availability included Austria (747 cycles/million), Germany (830 cycles), Italy (863 cycles) and UK (879 cycles).

Success rates from a single "fresh" treatment cycle of IVF and ICSI -- as first indicated in data for 2008 presented last year -- seem to have stabilised, at around 32% pregnancy rate per embryo transfer (and 28% per aspiration). Dr Ferraretti said there had been a notable decline in the number of embryos transferred, with cumulative delivery rates, which include the transfer of frozen/thawed embryos from the same stimulation cycle, now representing "the best indicator of outcome." By using this endpoint, she explained, delivery rates can increase substantially while maintaining a very low multiple rate.

See more here:
World's number of IVF and ICSI babies has now reached a calculated total of 5 million

Childless women with fertility problems at higher risk of hospitalization for psychiatric disorders

Public release date: 2-Jul-2012 [ | E-mail | Share ]

Contact: Christine Bauquis christine@eshre.eu 32-499-258-046 European Society of Human Reproduction and Embryology

Istanbul, 2 July 2012: While many small studies have shown a relationship between infertility and psychological distress, reporting a high prevalence of anxiety, mood disorders and depressive symptoms, few have studied the psychological effect of childlessness on a large population basis. Now, based on the largest cohort of women with fertility problems compiled to date, Danish investigators have shown that women who remained childless after their first investigation for infertility had more hospitalisations for psychiatric disorders than women who had at least one child following their investigation.

The results of the study were presented today at the annual meeting of ESHRE (European Society of Human Reproduction and Embryology) by Dr Birgitte Baldur-Felskov, an epidemiologist from the Danish Cancer Research Center in Copenhagen.

Most studies of this kind have been based on single clinics and self-reported psychological effects. This study, however, was a nationwide follow-up of 98,737 Danish women investigated for infertility between 1973 and 2008, who were then cross-linked via Denmark's population-based registries to the Danish Psychiatric Central Registry. This provided information on hospitalisations for psychiatric disorders, which were divided into an inclusive group of "all mental disorders", and six discharge sub-groups which comprised "alcohol and intoxicant abuse", "schizophrenia and psychoses", "affective disorders including depression", "anxiety, adjustment and obsessive compulsive disorder", "eating disorders", and "other mental disorders".

All women were followed from the date of their initial fertility investigation until the date of psychiatric event, date of emigration, date of death, date of hospitalisation or 31st December 2008, whichever came first. Such studies, said Dr Baldur-Felskov, could only be possible in somewhere like Denmark, where each citizen has a personal identification number which can be linked to any or all of the country's diagnostic registries.

Results of the study showed that, over an average follow-up time of 12.6 years (representing 1,248,243 woman-years), 54% of the 98,737 women in the cohort did have a baby. Almost 5000 women from the entire cohort were hospitalised for a psychiatric disorder, the most common discharge diagnosis being "anxiety, adjustment and obsessive compulsive disorders" followed by "affective disorders including depression".

However, those women who remained childless after their initial fertility investigation had a statistically significant (18%) higher risk of hospitalisations for all mental disorders than the women who went on to have a baby; the risk was also significantly greater for alcohol/substance abuse (by 103%), schizophrenia (by 47%) and other mental disorders (by 43%). The study also showed that childlessness increased the risk of eating disorders by 47%, although this was not statistically significant.

However, the most commonly seen discharge diagnosis in the entire cohort (anxiety, adjustment and obsessive compulsive disorders) was not affected by fertility status.

Commenting on the study's results, Dr Baldur-Felskov said: "Our study showed that women who remained childless after fertility evaluation had an 18% higher risk of all mental disorders than the women who did have at least one baby. These higher risks were evident in alcohol and substance abuse, schizophrenia and eating disorders, although appeared lower in affective disorders including depression.

Go here to read the rest:
Childless women with fertility problems at higher risk of hospitalization for psychiatric disorders

Higher levels of public reimbursement positively influence national birth rates and reduce unmet needs in subfertile …

Public release date: 2-Jul-2012 [ | E-mail | Share ]

Contact: Christine Bauquis christine@eshre.eu 32-499-258-046 European Society of Human Reproduction and Embryology

Istanbul, 2 July 2012: The state funding of fertility treatment through public reimbursement policies has a direct influence on national birth rates. Lower levels of reimbursement are correlated with higher unmet needs for treatment, while more generous reimbursement policies increase access to treatment and may even make a measurable contribution to national birth rates.

The findings come from a study reported here today at the annual meeting of ESHRE (European Society of Human Reproduction and Embryology). The results, says health economist Dr Mark Connolly from the University of Groningen in the Netherlands, reflect the wide variety of reimbursement policies throughout Europe and come at a time when many national and local authorities have made plans to cut back their IVF funding as a cost-cutting initiative.(1)

Dr Connolly and colleagues quantified the reimbursement policies of 23 European countries, using an index score ranging from 0 to 18; the higher index scores indicated fuller state funding/reimbursement for treatment. The countries with the most generous funding policies were Belgium, France and Slovenia (with scores between 14 and 18); those with the least generous were the UK, Russia and Ireland (all with scores under 3).

These index scores were then correlated with treatment practice and outcomes in each of the 23 countries. Results first showed a significant relationship between the level of reimbursement and the annual contribution of assisted reproduction (ART) births to national birth numbers. " This finding," said Dr Connolly, "has important policy implications for national authorities concerned about ageing populations and interested in policies for influencing national birth rates. Although the influence on birth rates is small, the relationship is positive and provides an opportunity to compare with other policies implemented by local and national governments to influence birth rates."(2)

Results also showed that in countries with higher levels of reimbursement a higher volume of ART cycles is performed. For example, ESHRE monitoring data for 2008 showed that more ART cycles per million population were performed in Belgium and Denmark (2479 and 2450 ART cycles per million population in 2008) than in Germany, Italy and UK (801, 807 and 825 cycles). "If one considers medical need is similar across countries," said Dr Connolly, "then the data here suggest a great unmet need in those countries with limited reimbursement."

However, the study did not show any significant relationship between reimbursement policies and access to care for women of different age groups. This would suggest, said Dr Connolly, that there is no oversupply of treatment in countries with generous state funding. "This is a welcome finding," he added, "because it suggests treatment is based on medical need and not simply on the availability and accessibility of reimbursed treatment."

While the study did not find correlations between reimbursement and patient age (or deliveries per cycle, or multiple embryo transfers), there was a trend towards more singleton deliveries in countries with higher levels of reimbursement, suggesting that results in poorly reimbursed countries are more dependent on a single cycle of treatment than on single embryo transfers in cumulative cycles.

The authors of the study hope that health ministries at this difficult economic time consider the broader implications of access to fertility care and the cost consequences of not funding. As shown by this study, limited funding for ART will result in fewer children being born each year and inequitable access to treatment.

Read the original:
Higher levels of public reimbursement positively influence national birth rates and reduce unmet needs in subfertile ...

Food issues in the spotlight

Food security and sustainable agriculture was one of the most important topics at the recent Rio+20 Summit, for the simple reason that all of us have to eat to survive, and agriculture has to be ecologically sustainable for production to continue into the future.

While the negotiators were busily hammering out a quite satisfactory text on this topic in a small room, a more interesting discussion was taking place on Food and Nutrition Security in the huge plenary hall sitting 2,000 people.

I was one of the 10 panellists in this debate, part of the seven Sustainable Development Dialogues that were organised by the Brazilian government as part of the official summit programme.

Other topics in the dialogue series included the global financial crisis, unemployment, energy, oceans, cities, forests and, production and consumption patterns.

In the food dialogue, the panellists included former prime minister of Mozambique Luisa Dias Diogo, former UN Human Rights Commissioner Mary Robinson, Indian ecologist Vandana Shiva, Slow Food Movement founder Carlo Petrini, World Economic Forum vice-president Josette Sheeran, Brazilian academic Renato Maluf and several representatives of farmers organisations.

Before the dialogue, there was a months-long Internet-based interactive discussion open to all, and the thousands that took part proposed solutions to the food problem.

The panel was to discuss which proposals were most important, and forward them to the heads of states meeting a few days later.

There was significant agreement among the panellists that small farmers in developing countries, and especially women, were the key to both the present and the future of agriculture.

Empowering small farmers through access to land, credit, subsidies, storage facilities and transport were thus essential.

The expansion of national budgets and aid allocation to small-scale agriculture is thus a priority, as is the strengthening of farmers organisations that can fight for their interests.

Visit link:
Food issues in the spotlight